Company Analysis

Adial Pharmaceuticals, Inc (ADIL)

Nasdaq: ADIL · Pharmaceutical Preparations · Charlottesville, VA · filing with the SEC since 2011
Grade4.4
◀ Past 3.2● Present 3.1▶ Future 6.3
6 est.

Who runs Adial Pharmaceuticals, Inc

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Davidson Matt
President and CEO. First filing Jun 2026, latest Nov 4, 2026, 0 filings in all.
Officers reporting now
5
of 9 people with a filing in the last fifteen months
Directors reporting now
4
14 people on the record since 2018
Officerssales are open-market, Nov 4, 2025 to Nov 4, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Davidson MattPresident and CEOJun 2026Nov 4, 2026none
Saiki JulieChief Strategy OfficerNov 2026Nov 4, 2026none
Claiborne Cary JChief Executive OfficerNov 2021Apr 9, 2026none
Shah VinayChief Financial OfficerNov 2024Apr 9, 2026none
Goodman TonyChief Operating OfficerJul 2018Apr 9, 2026none
Directorssales are open-market, Nov 4, 2025 to Nov 4, 2026
NameRoleFirst filingLatest filingSales, 12 months
Young Wendy B.directorJun 2026Sep 21, 2026none
Anderson J. KermitdirectorJul 2018Apr 9, 2026none
Gilliland Robertson H.directorJul 2018Apr 9, 2026none
Schuyler KevindirectorJul 2018Apr 9, 2026none
Owners of more than 10% of a classsales are open-market, Nov 4, 2025 to Nov 4, 2026
NameRoleFirst filingLatest filingSales, 12 months
Coastlands Capital LP10% ownerJun 2026Nov 3, 2026none
Earlier names on the record6, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton ADIL · research, not advice